Phyllis Ioannou

Business Unit Head, Neuroscience and Rare Disease

Phyllis Ioannou joined Ipsen Canada in 2020, bringing over 20 years of pharmaceutical sales and marketing experiencing to her role. She provides commercial and cross-functional strategic and operational leadership for the neuroscience and rare disease portfolio and is responsible for developing and implementing strategies to grow the franchises. Phyllis also leads marketing activities to support local development and launch planning.

Before joining Ipsen Canada, Phyllis held a number of roles with Elvium Life Sciences that included sales leadership, new product strategy and innovation, and strategic portfolio life cycle management. Previously, she held progressive roles at Allergan Canada in the fields of ophthalmology and neuroscience, including 10 years of sales and marketing leadership roles in the neurotoxin space. She additionally was a founding member of the ZS Associates Toronto office, where she consulted in areas of sales force sizing and optimization, sales force effectiveness, and go-to-market strategy.

Phyllis holds a Bachelor of Commerce, Finance and Managerial Law from Concordia University, and an MBA from the Richard Ivey School of Business at Western University.

Our mission

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare disease.

Find out more about us or see other members of our leadership team.


Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products


Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

©2020 Ipsen Biopharmaceuticals, Inc. All rights reserved. June 2020 CR-CA-000013